Biologics Contract Manufacturing Market Size, Share & Trends Report

Biologics Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (MABs, Recombinant Protein), By Indication (Oncology, CVDs), By Region (Europe, APAC), And Segment Forecasts, 2022 - 2030

Report ID: GVR-4-68039-921-6
Number of Pages: 180
Format: Electronic (PDF)

Historical Range: 2017 - 2020
Industry: Healthcare

Market Segmentation

Biologics Contract Manufacturing Product Outlook (Revenue, USD Million, 2017 - 2030)
- MABs
- Recombinant Protein
- Others
Biologics Contract Manufacturing Indication Outlook (Revenue, USD Million, 2017 - 2030)
- Oncology
- Immunological Disorders
- Cardiovascular Disorders
- Hematological Disorders
- Others
Biologics Contract Manufacturing Regional Outlook (Revenue, USD Million, 2017 - 2030)
- North America
  - North America Biologics Contract Manufacturing Market, By Product
    - MABs
    - Recombinant Protein
    - Others
  - North America Biologics Contract Manufacturing Market, By Indication
    - Oncology
    - Immunological Disorders
    - Cardiovascular Disorders
    - Hematological Disorders
    - Others
  - U.S.
    - U.S. Biologics Contract Manufacturing Market, By Source
      - MABs
      - Recombinant Protein
      - Others
    - U.S. Biologics Contract Manufacturing Market, By Service
      - Oncology
      - Immunological Disorders
      - Cardiovascular Disorders
      - Hematological Disorders
      - Others
  - Canada
    - Canada Biologics Contract Manufacturing Market, By Product
      - MABs
      - Recombinant Protein
      - Others
    - Canada Biologics Contract Manufacturing Market, By Indication
      - Oncology
      - Immunological Disorders
      - Cardiovascular Disorders
      - Hematological Disorders
      - Others
- Europe
- Asia Pacific
  - Asia Pacific Biologics Contract Manufacturing Market, By Product
    - MABs
    - Recombinant Protein
    - Others
  - Asia Pacific Biologics Contract Manufacturing Market, By Indication
    - Oncology
    - Immunological Disorders
    - Cardiovascular Disorders
    - Hematological Disorders
    - Others
  - China
    - China Biologics Contract Manufacturing Market, By Product
      - MABs
      - Recombinant Protein
      - Others
    - China Biologics Contract Manufacturing Market, By Indication
      - Oncology
      - Immunological Disorders
      - Cardiovascular Disorders
      - Hematological Disorders
      - Others
  - Japan
    - Japan Biologics Contract Manufacturing Market, By Product
      - MABs
      - Recombinant Protein
      - Others
    - Japan Biologics Contract Manufacturing Market, By Indication
      - Oncology
      - Immunological Disorders
      - Cardiovascular Disorders
      - Hematological Disorders
      - Others
  - India
    - India Biologics Contract Manufacturing Market, By Product
      - MABs
      - Recombinant Protein
      - Others
    - India Biologics Contract Manufacturing Market, By Indication
      - Oncology
      - Immunological Disorders
      - Cardiovascular Disorders
      - Hematological Disorders
      - Others
  - Australia
    - Australia Biologics Contract Manufacturing Market, By Product
      - MABs
      - Recombinant Protein
      - Others
    - Australia Biologics Contract Manufacturing Market, By Indication
      - Oncology
      - Immunological Disorders
      - Cardiovascular Disorders
      - Hematological Disorders
      - Others
  - South Korea
    - South Korea Biologics Contract Manufacturing Market, By Product
      - MABs
      - Recombinant Protein
      - Others
    - South Korea Biologics Contract Manufacturing Market, By Indication
      - Oncology
      - Immunological Disorders
      - Cardiovascular Disorders
      - Hematological Disorders
      - Others
- Latin America
  - Latin America Biologics Contract Manufacturing Market, By Product
    - MABs
    - Recombinant Protein
    - Others
  - Latin America Biologics Contract Manufacturing Market, By Indication
    - Oncology
    - Immunological Disorders
    - Cardiovascular Disorders
    - Hematological Disorders
    - Others
  - Brazil
    - Brazil Biologics Contract Manufacturing Market, By Product
      - MABs
      - Recombinant Protein
      - Others
    - Brazil Biologics Contract Manufacturing Market, By Indication
      - Oncology
      - Immunological Disorders
      - Cardiovascular Disorders
      - Hematological Disorders
      - Others
  - Mexico
    - Mexico Biologics Contract Manufacturing Market, By Product
      - MABs
      - Recombinant Protein
      - Others
    - Mexico Biologics Contract Manufacturing Market, By Indication
      - Oncology
      - Immunological Disorders
      - Cardiovascular Disorders
      - Hematological Disorders
      - Others
  - Argentina
    - Argentina Biologics Contract Manufacturing Market, By Product
      - MABs
      - Recombinant Protein
      - Others
    - Argentina Biologics Contract Manufacturing Market, By Indication
      - Oncology
      - Immunological Disorders
      - Cardiovascular Disorders
      - Hematological Disorders
      - Others
  - Colombia
    - Colombia Biologics Contract Manufacturing Market, By Product
      - MABs
      - Recombinant Protein
      - Others
    - Colombia Biologics Contract Manufacturing Market, By Indication
      - Oncology
      - Immunological Disorders
      - Cardiovascular Disorders
      - Hematological Disorders
      - Others
- Middle East & Africa (MEA)
  - MEA Biologics Contract Manufacturing Market, By Product
    - MABs
    - Recombinant Protein
    - Others
  - MEA Biologics Contract Manufacturing Market, By Indication
    - Oncology
    - Immunological Disorders
    - Cardiovascular Disorders
    - Hematological Disorders
    - Others
  - South Africa
    - South Africa Biologics Contract Manufacturing Market, By Product
      - MABs
      - Recombinant Protein
      - Others
    - South Africa Biologics Contract Manufacturing Market, By Indication
      - Oncology
      - Immunological Disorders
      - Cardiovascular Disorders
      - Hematological Disorders
      - Others
  - Saudi Arabia
    - Saudi Arabia Biologics Contract Manufacturing Market, By Product
      - MABs
      - Recombinant Protein
      - Others
    - Saudi Arabia Biologics Contract Manufacturing Market, By Indication
      - Oncology
      - Immunological Disorders
      - Cardiovascular Disorders
      - Hematological Disorders
      - Others
  - UAE
    - UAE Biologics Contract Manufacturing Market, By Product
      - MABs
      - Recombinant Protein
      - Others
    - UAE Biologics Contract Manufacturing Market, By Indication
      - Oncology
      - Immunological Disorders
      - Cardiovascular Disorders
      - Hematological Disorders
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2017 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.